Eye drop showdown: which cyclosporine boosts tear glands best?
NCT ID NCT07368595
First seen Jan 31, 2026 · Last updated May 04, 2026 · Updated 16 times
Summary
This study compares two approved cyclosporine eye drops (Vevye® and a generic) to see which one better increases mucus-producing cells in the eyes of people with dry eye disease. Sixty adults will use the drops daily for 8 weeks and have eye exams every 2 weeks. The goal is to find which treatment improves eye surface health faster and more effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.